Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion type Assertion NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_head.
- NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion description "[Screening for factor V Leiden and prothrombin G20210A, with prolonged prophylaxis of double carriers, is cost-effective in most patients with VTE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_provenance.
- NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion evidence source_evidence_literature NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_provenance.
- NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion SIO_000772 11435632 NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_provenance.
- NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion wasDerivedFrom befree-20140225 NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_provenance.
- NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion wasGeneratedBy ECO_0000203 NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_provenance.